These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25055039)

  • 1. The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.
    Yu W; Li C; Fu X; Cui Z; Liu X; Fan L; Zhang G; Ma J
    PLoS One; 2014; 9(7):e102872. PubMed ID: 25055039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV.
    Gopalappa C; Stover J; Shaffer N; Mahy M
    AIDS; 2014 Jan; 28 Suppl 1():S5-14. PubMed ID: 24468947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
    Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana.
    VanDeusen A; Paintsil E; Agyarko-Poku T; Long EF
    BMC Infect Dis; 2015 Mar; 15():130. PubMed ID: 25887574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV.
    Keshmiri R; Coyte PC; Laporte A; Sheth PM; Loutfy M
    Medicine (Baltimore); 2019 Jun; 98(23):e15841. PubMed ID: 31169687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider- and patient-level costs associated with providing antiretroviral therapy during the postpartum phase to women living with HIV in South Africa: A cost comparison of three postpartum models of care.
    Cunnama L; Abrams EJ; Myer L; Phillips TK; Dugdale CM; Ciaranello AL; Zerbe A; Iyun V; MacQuilkan K; Daries V; Sinanovic E
    Trop Med Int Health; 2020 Dec; 25(12):1553-1567. PubMed ID: 32959434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda.
    Binagwaho A; Pegurri E; Drobac PC; Mugwaneza P; Stulac SN; Wagner CM; Karema C; Tsague L
    PLoS One; 2013; 8(2):e54180. PubMed ID: 23437040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia.
    Ishikawa N; Shimbo T; Miyano S; Sikazwe I; Mwango A; Ghidinelli MN; Syakantu G
    PLoS One; 2014; 9(3):e90991. PubMed ID: 24604067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.
    Ngambi PG; Kalungia AC; Law MR; Kalemeera F; Truter I; Godman B; Munkombwe D
    Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):459-467. PubMed ID: 28770641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV.
    O'Brien L; Shaffer N; Sangrujee N; Abimbola TO
    Bull World Health Organ; 2014 Mar; 92(3):162-70. PubMed ID: 24700975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.
    Tweya H; Keiser O; Haas AD; Tenthani L; Phiri S; Egger M; Estill J
    AIDS; 2016 Mar; 30(6):953-62. PubMed ID: 26691682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.
    Dunning L; Francke JA; Mallampati D; MacLean RL; Penazzato M; Hou T; Myer L; Abrams EJ; Walensky RP; Leroy V; Freedberg KA; Ciaranello A
    PLoS Med; 2017 Nov; 14(11):e1002446. PubMed ID: 29161262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
    Price JT; Wheeler SB; Stranix-Chibanda L; Hosek SG; Watts DH; Siberry GK; Spiegel HM; Stringer JS; Chi BH
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S145-53. PubMed ID: 27355502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing HIV retesting during pregnancy and postpartum in four countries: a cost-effectiveness analysis.
    Meisner J; Roberts DA; Rodriguez P; Sharma M; Newman Owiredu M; Gomez B; de Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Farid S; Essajee S; Jamil MS; Baggaley R; Johnson C; Drake AL
    J Int AIDS Soc; 2021 Apr; 24(4):e25686. PubMed ID: 33787064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa.
    Bobat R; Moodley D; Coutsoudis A; Coovadia H
    AIDS; 1997 Nov; 11(13):1627-33. PubMed ID: 9365768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings.
    Dugdale CM; Ufio O; Alba C; Permar SR; Stranix-Chibanda L; Cunningham CK; Fouda GG; Myer L; Weinstein MC; Leroy V; McFarland EJ; Freedberg KA; Ciaranello AL
    J Int AIDS Soc; 2023 Jan; 26(1):e26052. PubMed ID: 36604316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
    Kesho Bora Study Group
    Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a package of interventions for expedited antiretroviral therapy initiation during pregnancy in Cape Town, South Africa.
    Zulliger R; Black S; Holtgrave DR; Ciaranello AL; Bekker LG; Myer L
    AIDS Behav; 2014 Apr; 18(4):697-705. PubMed ID: 24122044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.